Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Merck
McKinsey
Boehringer Ingelheim
Dow

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: IMATINIB MESYLATE


Email this page to a colleague

« Back to Dashboard

IMATINIB MESYLATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novartis GLEEVEC imatinib mesylate TABLET;ORAL 021588 NDA Novartis Pharmaceuticals Corporation 0078-0401-34 90 TABLET in 1 BOTTLE (0078-0401-34) 2001-05-15
Novartis GLEEVEC imatinib mesylate TABLET;ORAL 021588 NDA Novartis Pharmaceuticals Corporation 0078-0649-30 30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30) 2014-12-23
Sun Pharm IMATINIB MESYLATE imatinib mesylate TABLET;ORAL 078340 ANDA NorthStar RxLLC 16714-704-01 90 TABLET, FILM COATED in 1 BOTTLE (16714-704-01) 2017-11-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Dow
Harvard Business School
Boehringer Ingelheim